Clinical Benefits of Lactoferrin for Infants and Children
To discuss the potential clinical benefits of lactoferrin in preterm and term infants, as well as in young children and to review information on the burden of neonatal sepsis. Current evidence on the mechanisms that explain the role of human milk in the neonatal and infant anti-infective responses w...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Manzoni, Paolo [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2016transfer abstract |
|---|
| Schlagwörter: |
|---|
| Umfang: |
10 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Media usage diminishes memory for experiences - Tamir, Diana I. ELSEVIER, 2018, St. Louis, Mo |
|---|---|
| Übergeordnetes Werk: |
volume:173 ; year:2016 ; pages:43-52 ; extent:10 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.jpeds.2016.02.075 |
|---|
| Katalog-ID: |
ELV014668742 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV014668742 | ||
| 003 | DE-627 | ||
| 005 | 20230625113726.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180602s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jpeds.2016.02.075 |2 doi | |
| 028 | 5 | 2 | |a GBVA2016023000011.pica |
| 035 | |a (DE-627)ELV014668742 | ||
| 035 | |a (ELSEVIER)S0022-3476(16)00298-5 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 150 |q VZ |
| 084 | |a LING |q DE-30 |2 fid | ||
| 084 | |a 77.00 |2 bkl | ||
| 100 | 1 | |a Manzoni, Paolo |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Clinical Benefits of Lactoferrin for Infants and Children |
| 264 | 1 | |c 2016transfer abstract | |
| 300 | |a 10 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a To discuss the potential clinical benefits of lactoferrin in preterm and term infants, as well as in young children and to review information on the burden of neonatal sepsis. Current evidence on the mechanisms that explain the role of human milk in the neonatal and infant anti-infective responses will be briefly reviewed and preclinical research data on the potential mechanisms of action by which lactoferrin may impact infant gut health, gut immune development and functions, including the lactoferrin effects on the neonatal microbiome, will be examined. Finally, updated translational research on lactoferrin will be presented and discussed and the current evidence from prospective randomized controlled trials in neonates, infants, and toddlers will be analyzed. These randomized controlled trials demonstrate that lactoferrin has a clinically significant impact on feeding, the microbiome, and clinical outcomes in neonates and infants. | ||
| 520 | |a To discuss the potential clinical benefits of lactoferrin in preterm and term infants, as well as in young children and to review information on the burden of neonatal sepsis. Current evidence on the mechanisms that explain the role of human milk in the neonatal and infant anti-infective responses will be briefly reviewed and preclinical research data on the potential mechanisms of action by which lactoferrin may impact infant gut health, gut immune development and functions, including the lactoferrin effects on the neonatal microbiome, will be examined. Finally, updated translational research on lactoferrin will be presented and discussed and the current evidence from prospective randomized controlled trials in neonates, infants, and toddlers will be analyzed. These randomized controlled trials demonstrate that lactoferrin has a clinically significant impact on feeding, the microbiome, and clinical outcomes in neonates and infants. | ||
| 650 | 7 | |a LOS |2 Elsevier | |
| 650 | 7 | |a RCT |2 Elsevier | |
| 650 | 7 | |a ROP |2 Elsevier | |
| 650 | 7 | |a VLBW |2 Elsevier | |
| 650 | 7 | |a H2B |2 Elsevier | |
| 650 | 7 | |a NICU |2 Elsevier | |
| 650 | 7 | |a ICU |2 Elsevier | |
| 650 | 7 | |a bLF |2 Elsevier | |
| 650 | 7 | |a LGG |2 Elsevier | |
| 650 | 7 | |a NEC |2 Elsevier | |
| 773 | 0 | 8 | |i Enthalten in |n Mosby |a Tamir, Diana I. ELSEVIER |t Media usage diminishes memory for experiences |d 2018 |g St. Louis, Mo |w (DE-627)ELV001345303 |
| 773 | 1 | 8 | |g volume:173 |g year:2016 |g pages:43-52 |g extent:10 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.jpeds.2016.02.075 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a FID-LING | ||
| 936 | b | k | |a 77.00 |j Psychologie: Allgemeines |q VZ |
| 951 | |a AR | ||
| 952 | |d 173 |j 2016 |h 43-52 |g 10 |y 173.2016, S43-, (10 S.) | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
p m pm |
|---|---|
| matchkey_str |
manzonipaolo:2016----:lncleeisfatfrifrna |
| hierarchy_sort_str |
2016transfer abstract |
| bklnumber |
77.00 |
| publishDate |
2016 |
| allfields |
10.1016/j.jpeds.2016.02.075 doi GBVA2016023000011.pica (DE-627)ELV014668742 (ELSEVIER)S0022-3476(16)00298-5 DE-627 ger DE-627 rakwb eng 610 610 DE-600 150 VZ LING DE-30 fid 77.00 bkl Manzoni, Paolo verfasserin aut Clinical Benefits of Lactoferrin for Infants and Children 2016transfer abstract 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier To discuss the potential clinical benefits of lactoferrin in preterm and term infants, as well as in young children and to review information on the burden of neonatal sepsis. Current evidence on the mechanisms that explain the role of human milk in the neonatal and infant anti-infective responses will be briefly reviewed and preclinical research data on the potential mechanisms of action by which lactoferrin may impact infant gut health, gut immune development and functions, including the lactoferrin effects on the neonatal microbiome, will be examined. Finally, updated translational research on lactoferrin will be presented and discussed and the current evidence from prospective randomized controlled trials in neonates, infants, and toddlers will be analyzed. These randomized controlled trials demonstrate that lactoferrin has a clinically significant impact on feeding, the microbiome, and clinical outcomes in neonates and infants. To discuss the potential clinical benefits of lactoferrin in preterm and term infants, as well as in young children and to review information on the burden of neonatal sepsis. Current evidence on the mechanisms that explain the role of human milk in the neonatal and infant anti-infective responses will be briefly reviewed and preclinical research data on the potential mechanisms of action by which lactoferrin may impact infant gut health, gut immune development and functions, including the lactoferrin effects on the neonatal microbiome, will be examined. Finally, updated translational research on lactoferrin will be presented and discussed and the current evidence from prospective randomized controlled trials in neonates, infants, and toddlers will be analyzed. These randomized controlled trials demonstrate that lactoferrin has a clinically significant impact on feeding, the microbiome, and clinical outcomes in neonates and infants. LOS Elsevier RCT Elsevier ROP Elsevier VLBW Elsevier H2B Elsevier NICU Elsevier ICU Elsevier bLF Elsevier LGG Elsevier NEC Elsevier Enthalten in Mosby Tamir, Diana I. ELSEVIER Media usage diminishes memory for experiences 2018 St. Louis, Mo (DE-627)ELV001345303 volume:173 year:2016 pages:43-52 extent:10 https://doi.org/10.1016/j.jpeds.2016.02.075 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-LING 77.00 Psychologie: Allgemeines VZ AR 173 2016 43-52 10 173.2016, S43-, (10 S.) 045F 610 |
| spelling |
10.1016/j.jpeds.2016.02.075 doi GBVA2016023000011.pica (DE-627)ELV014668742 (ELSEVIER)S0022-3476(16)00298-5 DE-627 ger DE-627 rakwb eng 610 610 DE-600 150 VZ LING DE-30 fid 77.00 bkl Manzoni, Paolo verfasserin aut Clinical Benefits of Lactoferrin for Infants and Children 2016transfer abstract 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier To discuss the potential clinical benefits of lactoferrin in preterm and term infants, as well as in young children and to review information on the burden of neonatal sepsis. Current evidence on the mechanisms that explain the role of human milk in the neonatal and infant anti-infective responses will be briefly reviewed and preclinical research data on the potential mechanisms of action by which lactoferrin may impact infant gut health, gut immune development and functions, including the lactoferrin effects on the neonatal microbiome, will be examined. Finally, updated translational research on lactoferrin will be presented and discussed and the current evidence from prospective randomized controlled trials in neonates, infants, and toddlers will be analyzed. These randomized controlled trials demonstrate that lactoferrin has a clinically significant impact on feeding, the microbiome, and clinical outcomes in neonates and infants. To discuss the potential clinical benefits of lactoferrin in preterm and term infants, as well as in young children and to review information on the burden of neonatal sepsis. Current evidence on the mechanisms that explain the role of human milk in the neonatal and infant anti-infective responses will be briefly reviewed and preclinical research data on the potential mechanisms of action by which lactoferrin may impact infant gut health, gut immune development and functions, including the lactoferrin effects on the neonatal microbiome, will be examined. Finally, updated translational research on lactoferrin will be presented and discussed and the current evidence from prospective randomized controlled trials in neonates, infants, and toddlers will be analyzed. These randomized controlled trials demonstrate that lactoferrin has a clinically significant impact on feeding, the microbiome, and clinical outcomes in neonates and infants. LOS Elsevier RCT Elsevier ROP Elsevier VLBW Elsevier H2B Elsevier NICU Elsevier ICU Elsevier bLF Elsevier LGG Elsevier NEC Elsevier Enthalten in Mosby Tamir, Diana I. ELSEVIER Media usage diminishes memory for experiences 2018 St. Louis, Mo (DE-627)ELV001345303 volume:173 year:2016 pages:43-52 extent:10 https://doi.org/10.1016/j.jpeds.2016.02.075 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-LING 77.00 Psychologie: Allgemeines VZ AR 173 2016 43-52 10 173.2016, S43-, (10 S.) 045F 610 |
| allfields_unstemmed |
10.1016/j.jpeds.2016.02.075 doi GBVA2016023000011.pica (DE-627)ELV014668742 (ELSEVIER)S0022-3476(16)00298-5 DE-627 ger DE-627 rakwb eng 610 610 DE-600 150 VZ LING DE-30 fid 77.00 bkl Manzoni, Paolo verfasserin aut Clinical Benefits of Lactoferrin for Infants and Children 2016transfer abstract 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier To discuss the potential clinical benefits of lactoferrin in preterm and term infants, as well as in young children and to review information on the burden of neonatal sepsis. Current evidence on the mechanisms that explain the role of human milk in the neonatal and infant anti-infective responses will be briefly reviewed and preclinical research data on the potential mechanisms of action by which lactoferrin may impact infant gut health, gut immune development and functions, including the lactoferrin effects on the neonatal microbiome, will be examined. Finally, updated translational research on lactoferrin will be presented and discussed and the current evidence from prospective randomized controlled trials in neonates, infants, and toddlers will be analyzed. These randomized controlled trials demonstrate that lactoferrin has a clinically significant impact on feeding, the microbiome, and clinical outcomes in neonates and infants. To discuss the potential clinical benefits of lactoferrin in preterm and term infants, as well as in young children and to review information on the burden of neonatal sepsis. Current evidence on the mechanisms that explain the role of human milk in the neonatal and infant anti-infective responses will be briefly reviewed and preclinical research data on the potential mechanisms of action by which lactoferrin may impact infant gut health, gut immune development and functions, including the lactoferrin effects on the neonatal microbiome, will be examined. Finally, updated translational research on lactoferrin will be presented and discussed and the current evidence from prospective randomized controlled trials in neonates, infants, and toddlers will be analyzed. These randomized controlled trials demonstrate that lactoferrin has a clinically significant impact on feeding, the microbiome, and clinical outcomes in neonates and infants. LOS Elsevier RCT Elsevier ROP Elsevier VLBW Elsevier H2B Elsevier NICU Elsevier ICU Elsevier bLF Elsevier LGG Elsevier NEC Elsevier Enthalten in Mosby Tamir, Diana I. ELSEVIER Media usage diminishes memory for experiences 2018 St. Louis, Mo (DE-627)ELV001345303 volume:173 year:2016 pages:43-52 extent:10 https://doi.org/10.1016/j.jpeds.2016.02.075 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-LING 77.00 Psychologie: Allgemeines VZ AR 173 2016 43-52 10 173.2016, S43-, (10 S.) 045F 610 |
| allfieldsGer |
10.1016/j.jpeds.2016.02.075 doi GBVA2016023000011.pica (DE-627)ELV014668742 (ELSEVIER)S0022-3476(16)00298-5 DE-627 ger DE-627 rakwb eng 610 610 DE-600 150 VZ LING DE-30 fid 77.00 bkl Manzoni, Paolo verfasserin aut Clinical Benefits of Lactoferrin for Infants and Children 2016transfer abstract 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier To discuss the potential clinical benefits of lactoferrin in preterm and term infants, as well as in young children and to review information on the burden of neonatal sepsis. Current evidence on the mechanisms that explain the role of human milk in the neonatal and infant anti-infective responses will be briefly reviewed and preclinical research data on the potential mechanisms of action by which lactoferrin may impact infant gut health, gut immune development and functions, including the lactoferrin effects on the neonatal microbiome, will be examined. Finally, updated translational research on lactoferrin will be presented and discussed and the current evidence from prospective randomized controlled trials in neonates, infants, and toddlers will be analyzed. These randomized controlled trials demonstrate that lactoferrin has a clinically significant impact on feeding, the microbiome, and clinical outcomes in neonates and infants. To discuss the potential clinical benefits of lactoferrin in preterm and term infants, as well as in young children and to review information on the burden of neonatal sepsis. Current evidence on the mechanisms that explain the role of human milk in the neonatal and infant anti-infective responses will be briefly reviewed and preclinical research data on the potential mechanisms of action by which lactoferrin may impact infant gut health, gut immune development and functions, including the lactoferrin effects on the neonatal microbiome, will be examined. Finally, updated translational research on lactoferrin will be presented and discussed and the current evidence from prospective randomized controlled trials in neonates, infants, and toddlers will be analyzed. These randomized controlled trials demonstrate that lactoferrin has a clinically significant impact on feeding, the microbiome, and clinical outcomes in neonates and infants. LOS Elsevier RCT Elsevier ROP Elsevier VLBW Elsevier H2B Elsevier NICU Elsevier ICU Elsevier bLF Elsevier LGG Elsevier NEC Elsevier Enthalten in Mosby Tamir, Diana I. ELSEVIER Media usage diminishes memory for experiences 2018 St. Louis, Mo (DE-627)ELV001345303 volume:173 year:2016 pages:43-52 extent:10 https://doi.org/10.1016/j.jpeds.2016.02.075 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-LING 77.00 Psychologie: Allgemeines VZ AR 173 2016 43-52 10 173.2016, S43-, (10 S.) 045F 610 |
| allfieldsSound |
10.1016/j.jpeds.2016.02.075 doi GBVA2016023000011.pica (DE-627)ELV014668742 (ELSEVIER)S0022-3476(16)00298-5 DE-627 ger DE-627 rakwb eng 610 610 DE-600 150 VZ LING DE-30 fid 77.00 bkl Manzoni, Paolo verfasserin aut Clinical Benefits of Lactoferrin for Infants and Children 2016transfer abstract 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier To discuss the potential clinical benefits of lactoferrin in preterm and term infants, as well as in young children and to review information on the burden of neonatal sepsis. Current evidence on the mechanisms that explain the role of human milk in the neonatal and infant anti-infective responses will be briefly reviewed and preclinical research data on the potential mechanisms of action by which lactoferrin may impact infant gut health, gut immune development and functions, including the lactoferrin effects on the neonatal microbiome, will be examined. Finally, updated translational research on lactoferrin will be presented and discussed and the current evidence from prospective randomized controlled trials in neonates, infants, and toddlers will be analyzed. These randomized controlled trials demonstrate that lactoferrin has a clinically significant impact on feeding, the microbiome, and clinical outcomes in neonates and infants. To discuss the potential clinical benefits of lactoferrin in preterm and term infants, as well as in young children and to review information on the burden of neonatal sepsis. Current evidence on the mechanisms that explain the role of human milk in the neonatal and infant anti-infective responses will be briefly reviewed and preclinical research data on the potential mechanisms of action by which lactoferrin may impact infant gut health, gut immune development and functions, including the lactoferrin effects on the neonatal microbiome, will be examined. Finally, updated translational research on lactoferrin will be presented and discussed and the current evidence from prospective randomized controlled trials in neonates, infants, and toddlers will be analyzed. These randomized controlled trials demonstrate that lactoferrin has a clinically significant impact on feeding, the microbiome, and clinical outcomes in neonates and infants. LOS Elsevier RCT Elsevier ROP Elsevier VLBW Elsevier H2B Elsevier NICU Elsevier ICU Elsevier bLF Elsevier LGG Elsevier NEC Elsevier Enthalten in Mosby Tamir, Diana I. ELSEVIER Media usage diminishes memory for experiences 2018 St. Louis, Mo (DE-627)ELV001345303 volume:173 year:2016 pages:43-52 extent:10 https://doi.org/10.1016/j.jpeds.2016.02.075 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-LING 77.00 Psychologie: Allgemeines VZ AR 173 2016 43-52 10 173.2016, S43-, (10 S.) 045F 610 |
| language |
English |
| source |
Enthalten in Media usage diminishes memory for experiences St. Louis, Mo volume:173 year:2016 pages:43-52 extent:10 |
| sourceStr |
Enthalten in Media usage diminishes memory for experiences St. Louis, Mo volume:173 year:2016 pages:43-52 extent:10 |
| format_phy_str_mv |
Article |
| bklname |
Psychologie: Allgemeines |
| institution |
findex.gbv.de |
| topic_facet |
LOS RCT ROP VLBW H2B NICU ICU bLF LGG NEC |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Media usage diminishes memory for experiences |
| authorswithroles_txt_mv |
Manzoni, Paolo @@aut@@ |
| publishDateDaySort_date |
2016-01-01T00:00:00Z |
| hierarchy_top_id |
ELV001345303 |
| dewey-sort |
3610 |
| id |
ELV014668742 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV014668742</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230625113726.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180602s2016 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.jpeds.2016.02.075</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2016023000011.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV014668742</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0022-3476(16)00298-5</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">150</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">LING</subfield><subfield code="q">DE-30</subfield><subfield code="2">fid</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">77.00</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Manzoni, Paolo</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Clinical Benefits of Lactoferrin for Infants and Children</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016transfer abstract</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">10</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">To discuss the potential clinical benefits of lactoferrin in preterm and term infants, as well as in young children and to review information on the burden of neonatal sepsis. Current evidence on the mechanisms that explain the role of human milk in the neonatal and infant anti-infective responses will be briefly reviewed and preclinical research data on the potential mechanisms of action by which lactoferrin may impact infant gut health, gut immune development and functions, including the lactoferrin effects on the neonatal microbiome, will be examined. Finally, updated translational research on lactoferrin will be presented and discussed and the current evidence from prospective randomized controlled trials in neonates, infants, and toddlers will be analyzed. These randomized controlled trials demonstrate that lactoferrin has a clinically significant impact on feeding, the microbiome, and clinical outcomes in neonates and infants.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">To discuss the potential clinical benefits of lactoferrin in preterm and term infants, as well as in young children and to review information on the burden of neonatal sepsis. Current evidence on the mechanisms that explain the role of human milk in the neonatal and infant anti-infective responses will be briefly reviewed and preclinical research data on the potential mechanisms of action by which lactoferrin may impact infant gut health, gut immune development and functions, including the lactoferrin effects on the neonatal microbiome, will be examined. Finally, updated translational research on lactoferrin will be presented and discussed and the current evidence from prospective randomized controlled trials in neonates, infants, and toddlers will be analyzed. These randomized controlled trials demonstrate that lactoferrin has a clinically significant impact on feeding, the microbiome, and clinical outcomes in neonates and infants.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">LOS</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">RCT</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">ROP</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">VLBW</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">H2B</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">NICU</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">ICU</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">bLF</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">LGG</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">NEC</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Mosby</subfield><subfield code="a">Tamir, Diana I. ELSEVIER</subfield><subfield code="t">Media usage diminishes memory for experiences</subfield><subfield code="d">2018</subfield><subfield code="g">St. Louis, Mo</subfield><subfield code="w">(DE-627)ELV001345303</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:173</subfield><subfield code="g">year:2016</subfield><subfield code="g">pages:43-52</subfield><subfield code="g">extent:10</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.jpeds.2016.02.075</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">FID-LING</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">77.00</subfield><subfield code="j">Psychologie: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">173</subfield><subfield code="j">2016</subfield><subfield code="h">43-52</subfield><subfield code="g">10</subfield><subfield code="y">173.2016, S43-, (10 S.)</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
Manzoni, Paolo |
| spellingShingle |
Manzoni, Paolo ddc 610 ddc 150 fid LING bkl 77.00 Elsevier LOS Elsevier RCT Elsevier ROP Elsevier VLBW Elsevier H2B Elsevier NICU Elsevier ICU Elsevier bLF Elsevier LGG Elsevier NEC Clinical Benefits of Lactoferrin for Infants and Children |
| authorStr |
Manzoni, Paolo |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV001345303 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health 150 - Psychology |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DE-600 150 VZ LING DE-30 fid 77.00 bkl Clinical Benefits of Lactoferrin for Infants and Children LOS Elsevier RCT Elsevier ROP Elsevier VLBW Elsevier H2B Elsevier NICU Elsevier ICU Elsevier bLF Elsevier LGG Elsevier NEC Elsevier |
| topic |
ddc 610 ddc 150 fid LING bkl 77.00 Elsevier LOS Elsevier RCT Elsevier ROP Elsevier VLBW Elsevier H2B Elsevier NICU Elsevier ICU Elsevier bLF Elsevier LGG Elsevier NEC |
| topic_unstemmed |
ddc 610 ddc 150 fid LING bkl 77.00 Elsevier LOS Elsevier RCT Elsevier ROP Elsevier VLBW Elsevier H2B Elsevier NICU Elsevier ICU Elsevier bLF Elsevier LGG Elsevier NEC |
| topic_browse |
ddc 610 ddc 150 fid LING bkl 77.00 Elsevier LOS Elsevier RCT Elsevier ROP Elsevier VLBW Elsevier H2B Elsevier NICU Elsevier ICU Elsevier bLF Elsevier LGG Elsevier NEC |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| hierarchy_parent_title |
Media usage diminishes memory for experiences |
| hierarchy_parent_id |
ELV001345303 |
| dewey-tens |
610 - Medicine & health 150 - Psychology |
| hierarchy_top_title |
Media usage diminishes memory for experiences |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV001345303 |
| title |
Clinical Benefits of Lactoferrin for Infants and Children |
| ctrlnum |
(DE-627)ELV014668742 (ELSEVIER)S0022-3476(16)00298-5 |
| title_full |
Clinical Benefits of Lactoferrin for Infants and Children |
| author_sort |
Manzoni, Paolo |
| journal |
Media usage diminishes memory for experiences |
| journalStr |
Media usage diminishes memory for experiences |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology 100 - Philosophy & psychology |
| recordtype |
marc |
| publishDateSort |
2016 |
| contenttype_str_mv |
zzz |
| container_start_page |
43 |
| author_browse |
Manzoni, Paolo |
| container_volume |
173 |
| physical |
10 |
| class |
610 610 DE-600 150 VZ LING DE-30 fid 77.00 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Manzoni, Paolo |
| doi_str_mv |
10.1016/j.jpeds.2016.02.075 |
| dewey-full |
610 150 |
| title_sort |
clinical benefits of lactoferrin for infants and children |
| title_auth |
Clinical Benefits of Lactoferrin for Infants and Children |
| abstract |
To discuss the potential clinical benefits of lactoferrin in preterm and term infants, as well as in young children and to review information on the burden of neonatal sepsis. Current evidence on the mechanisms that explain the role of human milk in the neonatal and infant anti-infective responses will be briefly reviewed and preclinical research data on the potential mechanisms of action by which lactoferrin may impact infant gut health, gut immune development and functions, including the lactoferrin effects on the neonatal microbiome, will be examined. Finally, updated translational research on lactoferrin will be presented and discussed and the current evidence from prospective randomized controlled trials in neonates, infants, and toddlers will be analyzed. These randomized controlled trials demonstrate that lactoferrin has a clinically significant impact on feeding, the microbiome, and clinical outcomes in neonates and infants. |
| abstractGer |
To discuss the potential clinical benefits of lactoferrin in preterm and term infants, as well as in young children and to review information on the burden of neonatal sepsis. Current evidence on the mechanisms that explain the role of human milk in the neonatal and infant anti-infective responses will be briefly reviewed and preclinical research data on the potential mechanisms of action by which lactoferrin may impact infant gut health, gut immune development and functions, including the lactoferrin effects on the neonatal microbiome, will be examined. Finally, updated translational research on lactoferrin will be presented and discussed and the current evidence from prospective randomized controlled trials in neonates, infants, and toddlers will be analyzed. These randomized controlled trials demonstrate that lactoferrin has a clinically significant impact on feeding, the microbiome, and clinical outcomes in neonates and infants. |
| abstract_unstemmed |
To discuss the potential clinical benefits of lactoferrin in preterm and term infants, as well as in young children and to review information on the burden of neonatal sepsis. Current evidence on the mechanisms that explain the role of human milk in the neonatal and infant anti-infective responses will be briefly reviewed and preclinical research data on the potential mechanisms of action by which lactoferrin may impact infant gut health, gut immune development and functions, including the lactoferrin effects on the neonatal microbiome, will be examined. Finally, updated translational research on lactoferrin will be presented and discussed and the current evidence from prospective randomized controlled trials in neonates, infants, and toddlers will be analyzed. These randomized controlled trials demonstrate that lactoferrin has a clinically significant impact on feeding, the microbiome, and clinical outcomes in neonates and infants. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-LING |
| title_short |
Clinical Benefits of Lactoferrin for Infants and Children |
| url |
https://doi.org/10.1016/j.jpeds.2016.02.075 |
| remote_bool |
true |
| ppnlink |
ELV001345303 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| doi_str |
10.1016/j.jpeds.2016.02.075 |
| up_date |
2024-07-06T22:06:28.067Z |
| _version_ |
1803869055163039744 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV014668742</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230625113726.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180602s2016 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.jpeds.2016.02.075</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2016023000011.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV014668742</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0022-3476(16)00298-5</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">150</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">LING</subfield><subfield code="q">DE-30</subfield><subfield code="2">fid</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">77.00</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Manzoni, Paolo</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Clinical Benefits of Lactoferrin for Infants and Children</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016transfer abstract</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">10</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">To discuss the potential clinical benefits of lactoferrin in preterm and term infants, as well as in young children and to review information on the burden of neonatal sepsis. Current evidence on the mechanisms that explain the role of human milk in the neonatal and infant anti-infective responses will be briefly reviewed and preclinical research data on the potential mechanisms of action by which lactoferrin may impact infant gut health, gut immune development and functions, including the lactoferrin effects on the neonatal microbiome, will be examined. Finally, updated translational research on lactoferrin will be presented and discussed and the current evidence from prospective randomized controlled trials in neonates, infants, and toddlers will be analyzed. These randomized controlled trials demonstrate that lactoferrin has a clinically significant impact on feeding, the microbiome, and clinical outcomes in neonates and infants.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">To discuss the potential clinical benefits of lactoferrin in preterm and term infants, as well as in young children and to review information on the burden of neonatal sepsis. Current evidence on the mechanisms that explain the role of human milk in the neonatal and infant anti-infective responses will be briefly reviewed and preclinical research data on the potential mechanisms of action by which lactoferrin may impact infant gut health, gut immune development and functions, including the lactoferrin effects on the neonatal microbiome, will be examined. Finally, updated translational research on lactoferrin will be presented and discussed and the current evidence from prospective randomized controlled trials in neonates, infants, and toddlers will be analyzed. These randomized controlled trials demonstrate that lactoferrin has a clinically significant impact on feeding, the microbiome, and clinical outcomes in neonates and infants.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">LOS</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">RCT</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">ROP</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">VLBW</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">H2B</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">NICU</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">ICU</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">bLF</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">LGG</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">NEC</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Mosby</subfield><subfield code="a">Tamir, Diana I. ELSEVIER</subfield><subfield code="t">Media usage diminishes memory for experiences</subfield><subfield code="d">2018</subfield><subfield code="g">St. Louis, Mo</subfield><subfield code="w">(DE-627)ELV001345303</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:173</subfield><subfield code="g">year:2016</subfield><subfield code="g">pages:43-52</subfield><subfield code="g">extent:10</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.jpeds.2016.02.075</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">FID-LING</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">77.00</subfield><subfield code="j">Psychologie: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">173</subfield><subfield code="j">2016</subfield><subfield code="h">43-52</subfield><subfield code="g">10</subfield><subfield code="y">173.2016, S43-, (10 S.)</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.401017 |